Wordt geladen...
Fluorouracil Supplemented With Oxaliplatin or Irinotecan for Solid Tumors: Indications From Clinical Characteristics and Health Outcomes of Patients
Fluorouracil combined with oxaliplatin (FOLFOX) and fluorouracil combined with irinotecan (FOLFIRI) are both first-line clinical chemotherapy regimens. However, clinicians' selection of FOLFIRI or FOLFOX medication regimens and their effects on patients' health outcomes are not clear. The...
Bewaard in:
| Gepubliceerd in: | Front Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492525/ https://ncbi.nlm.nih.gov/pubmed/32984012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01542 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|